āĻšā§āĻŽCSL âĸ ASX
add
CSL Ltd
ā§§ā§ā§¨.ā§Ŧā§Ģ$
ā§¨ āĻāĻžāĻ¨ā§, ā§Ģ:ā§¨ā§¨:ā§¨ā§Ģ AM GMT +ā§§ā§§ · AUD · ASX · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻAU-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋAU-āĻ āĻšā§āĻĄāĻā§ā§āĻžāĻ°ā§āĻāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§§ā§ā§¨.ā§Ēā§¨$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§§ā§ā§¨.ā§Ļā§Ļ$ - ā§§ā§ā§Š.ā§Ēā§Ŧ$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§§ā§Ŧā§Ž.ā§Ļā§Ļ$ - ā§¨ā§¯ā§Ļ.ā§Šā§¨$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§Ž.ā§Šā§ŽāĻļāĻ¤Â āĻā§ AUD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§¯.ā§Ļā§ŽÂ āĻ˛āĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
ā§§ā§Ž.ā§ā§Ž
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
ā§§.ā§Žā§Š%
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
ASX
āĻāĻŦāĻ°ā§ āĻ°ā§ā§āĻā§
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (USD) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Šā§Ģā§Š.ā§ā§Ģ āĻā§ | ā§Ē.ā§Žā§Ŧ% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§§ā§Ļā§Ž.ā§Šā§Ģ āĻā§ | ā§Š.ā§Ŧā§Š% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Ēā§¯.ā§ā§Ģ āĻā§ | ā§Šā§Ē.ā§¨ā§Ž% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | ā§§ā§Ē.ā§Ļā§Ŧ | ā§¨ā§Ž.ā§Ļā§Ģ% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | â | â |
EBITDA | ā§Žā§Š.ā§Ļā§Ģ āĻā§ | ā§Ģ.ā§Šā§¯% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§Ž.ā§ā§Ž% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§¨ā§§ā§Ģ.ā§ā§Ļ āĻā§ | ā§Šā§Ļ.ā§§ā§Ž% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§Š.ā§¯ā§ĒāĻļāĻ¤Â āĻā§ | ā§Š.ā§Ŧā§Š% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§§.ā§Žā§ĻāĻļāĻ¤Â āĻā§ | -ā§Š.ā§Šā§Ģ% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§¨.ā§§ā§ĒāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§Ēā§Ž.ā§Ēā§¨Â āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§Ē.ā§Šā§¨ | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§Ē.ā§¨ā§Š% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | ā§Ģ.ā§Ļā§Ŧ% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (USD) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Ēā§¯.ā§ā§Ģ āĻā§ | ā§Šā§Ē.ā§¨ā§Ž% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§§ā§§ā§Ģ.ā§§ā§Ļ āĻā§ | ā§Šā§Ģ.ā§Žā§§% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§¨ā§Ē.ā§¨ā§Ļ āĻā§ | ā§§ā§Š.ā§§ā§§% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§Ŧā§Š.ā§¯ā§Ģ āĻā§ | -ā§§ā§ā§¨.ā§§ā§Š% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | ā§Šā§§.ā§Ŧā§Ģ āĻā§ | ā§Ļ.ā§§ā§Ŧ% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | ā§Ēā§¨.ā§Žā§ŽÂ āĻā§ | ā§¨ā§§.ā§ā§Ļ% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ā§¯ā§§ā§Ŧ
āĻ¸āĻĻāĻ° āĻĻāĻĒā§āĻ¤āĻ°
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§¨ā§¯,ā§¯ā§Ļā§Ē
